XBIO - Xenetic Biosciences Inc logo

XBIO

Xenetic Biosciences Inc

Xenetic Biosciences develops biopharmaceuticals targeting oncology, focusing on immune-oncology technologies and cell-based therapies. Its pipeline includes treatments for pancreatic carcinoma, solid tumors, and anemia in chronic kidney disease.

โš•๏ธ Healthcare NASDAQ Listed 2014 $ USD
$1,000 invested 10 years ago โ†’$6today

Score Overview

1 Year
Score
Net Growth7.68%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth9.55%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score7.1
Net Growth56.16%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth180.93%
Rev Trend80%
Revenue Consistencyโ€”
10 Years
Score
Net Growth95.43%
Net Trend70%
Net Income Consistency
Rev Growth8.69%
Rev Trend80%
Revenue Consistency
All Time
Scoreโ€”
Net Growth82.70%
Net Trend67%
Net Income Consistency
Rev Growthโ€”
Rev Trend75%
Revenue Consistency

See the full market ranking โ†’

Xenetic Biosciences Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 436.94K to $ 2M and net income went from -$ 10M to -$ 2M. Revenue increased in 4 of those 5 years; net income in 4.

Between 2015 and 2025, revenue grew from $ 0.00 to $ 2M and net income went from -$ 12M to -$ 2M. Revenue increased in 8 of those 10 years; net income in 7.

Xenetic Biosciences Inc currently holds a 5-year HDB Score of 7.1 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 3.30โ€”
1 Year2025-08-12
$ 2.7918.28%
5 Years2021-08-12
$ 36.50-90.96%
10 Years2016-08-12
$ 540.00-99.39%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 3M-$ 2M$ 6M
2025$ 2M-$ 2M$ 7M
2024$ 2M-$ 3M$ 6M
2023$ 2M-$ 4M$ 8M
2022$ 1M-$ 6M$ 13M
2021$ 1M-$ 5M$ 18M
2020$ 436.94K-$ 10M$ 11M
2019$ 17.07K-$ 12M$ 10M
2018$ 0.00-$ 7M$ 571.61K
2017$ 7M-$ 3M$ 5M
2016$ 3M-$ 54M$ 4M
2015$ 0.00-$ 12M$ 132.23K
IPO2014$ 0.00-$ 14M$ 2M

Explore beyond XBIO

You're looking at Xenetic Biosciences Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies